Abstract
Antidepressant medication is generally considered the primary treatment for major depressive disorder (MDD), but recently antidepressant treatment has approached a crisis with current trials showing shrinking specific effects and growing placebo responses. The aim of the paper is to review the placebo problem within antidepressant treatment for MDD and to draw lines to similar problems within the field of psychotherapy. Although clinicians may profit from the large placebo response in their treatment of MDD, the small differences between active treatment and placebo groups found in controlled studies should be considered a reminder that there is a need for more efficacious treatments for MDD, medical as well as psychological.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
